VHL vitasora health limited

transgene key development milestones

  1. 520 Posts.

    Payment by Novartis of ?7.3m is due in April as provided for under the option agreement
    concluded in March 2010 for the development of TG4010.

    http://www.info-financiere.fr/upload/CNS/2010/04/FCCNS026613_20100419.pdf
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
2.7¢
Change
-0.002(6.90%)
Mkt cap ! $46.40M
Open High Low Value Volume
2.9¢ 3.0¢ 2.6¢ $22.40K 784.8K

Buyers (Bids)

No. Vol. Price($)
1 12646 2.7¢
 

Sellers (Offers)

Price($) Vol. No.
3.0¢ 523829 3
View Market Depth
Last trade - 15.59pm 10/09/2025 (20 minute delay) ?
VHL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.